1. Valdez BC, Wang G, Murray D, Nieto Y, Li Y, Shah J et al. Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implications. Exp Hematol 2013; 41: 719–730.
2. Andreesen R, Modolell M, Weltzien HU, Eibl H, Common HH, Löhr GW et al. Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Res 1978; 38: 894–899.
3. Chabot MC, Wykle RL, Modest EJ, Daniel LW . Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Cancer Res 1989; 49: 4441–4445.
4. Zeller WJ, Bauer S, Remmele T, Wowra B, Sturm V, Stricker H . Interstitial chemotherapy of experimental gliomas. Cancer Treat Rev 1990; 17: 183–189.
5. Dietzfelbinger HF, Kühn D, Zafferani M, Hanauske AR, Rastetter JW, Berdel WE . Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Cancer Res 1993; 53: 3747–3751.